Works matching AU Cebon, Jonathan

Results: 71

Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma.

Published in:

2021

By:

Arulananda, Surein;
O'Brien, Megan;
Evangelista, Marco;
Harris, Tiffany J.;
Steinohrt, Nikita S.;
Jenkins, Laura J.;
Walkiewicz, Marzena;
O'Donoghue, Robert J. J.;
Poh, Ashleigh R.;
Thapa, Bibhusal;
Williams, David S.;
Leong, Trishe;
Mariadason, John M.;
Li, Xia;
Cebon, Jonathan;
Lee, Erinna F.;
John, Thomas;
Fairlie, W. Douglas

Publication type:

Correction Notice

A novel BH3-mimetic, AZD0466, targeting BCL-XL and BCL-2 is effective in pre-clinical models of malignant pleural mesothelioma.

Published in:

Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00505-0

By:

Arulananda, Surein;
O'Brien, Megan;
Evangelista, Marco;
Jenkins, Laura J.;
Poh, Ashleigh R.;
Walkiewicz, Marzena;
Leong, Trishe;
Mariadason, John M.;
Cebon, Jonathan;
Balachander, Srividya B.;
Cidado, Justin R.;
Lee, Erinna F.;
John, Thomas;
Fairlie, Walter D.

Publication type:

Article

BCL-XL is an actionable target for treatment of malignant pleural mesothelioma.

Published in:

Cell Death Discovery, 2020, v. 6, n. 1, p. N.PAG, doi. 10.1038/s41420-020-00348-1

By:

Arulananda, Surein;
O'Brien, Megan;
Evangelista, Marco;
Harris, Tiffany J.;
Steinohrt, Nikita S.;
Jenkins, Laura J.;
Walkiewicz, Marzena;
O'Donoghue, Robert J. J.;
Poh, Ashleigh R.;
Thapa, Bibhusal;
Williams, David S.;
Leong, Trishe;
Mariadason, John M.;
Li, Xia;
Cebon, Jonathan;
Lee, Erinna F.;
John, Thomas;
Douglas Fairlie, W.

Publication type:

Article

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival.

Published in:

Cell Death & Disease, 2019, v. 10, n. 5, p. N.PAG, doi. 10.1038/s41419-019-1568-3

By:

Lee, Erinna F.;
Harris, Tiffany J.;
Tran, Sharon;
Evangelista, Marco;
Arulananda, Surein;
John, Thomas;
Ramnac, Celeste;
Hobbs, Chloe;
Zhu, Haoran;
Gunasingh, Gency;
Segal, David;
Behren, Andreas;
Cebon, Jonathan;
Dobrovic, Alexander;
Mariadason, John M.;
Strasser, Andreas;
Rohrbeck, Leona;
Haass, Nikolas K.;
Herold, Marco J.;
Fairlie, W. Douglas

Publication type:

Article

Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors.

Published in:

BMC Medical Genomics, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1755-8794-6-40

By:

Anaka, Matthew;
Hudson, Christopher;
Pu-Han Lo;
Hongdo Do;
Caballero, Otavia L.;
Davis, Ian D.;
Dobrovic, Alexander;
Cebon, Jonathan;
Behren, Andreas

Publication type:

Article

Association of good oncological response to therapy with the development of rheumatic immune‐related adverse events following PD‐1 inhibitor therapy.

Published in:

International Journal of Rheumatic Diseases, 2019, v. 22, n. 2, p. 297, doi. 10.1111/1756-185X.13444

By:

Liew, David F. L.;
Leung, Jessica L. Y.;
Liu, Bonnia;
Cebon, Jonathan;
Frauman, Albert G.;
Buchanan, Russell R. C.

Publication type:

Article

First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid Tumors.

Published in:

2016

By:

Dienstmann, Rodrigo;
Lassen, Ulrik;
Cebon, Jonathan;
Desai, Jayesh;
Brown, Michael;
Evers, Stefan;
Su, Fei;
Zhang, Weijiang;
Boisserie, Frederic;
Lestini, Brian;
Schostack, Kathleen;
Meresse, Valerie;
Tabernero, Josep;
Brown, Michael P

Publication type:

journal article

Low-dose cyclophosphamide enhances antigen-specific CD4 T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 507, doi. 10.1007/s00262-015-1656-x

By:

Klein, Oliver;
Davis, Ian;
McArthur, Grant;
Chen, Li;
Haydon, Andrew;
Parente, Phillip;
Dimopoulos, Nektaria;
Jackson, Heather;
Xiao, Kun;
Maraskovsky, Eugene;
Hopkins, Wendie;
Stan, Rodica;
Chen, Weisan;
Cebon, Jonathan

Publication type:

Article

Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 321, doi. 10.1007/s00262-012-1342-1

By:

Knights, Ashley;
Fucikova, Jitka;
Pasam, Anupama;
Koernig, Sandra;
Cebon, Jonathan

Publication type:

Article

Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 11, p. 1625, doi. 10.1007/s00262-011-1041-3

By:

Nicholaou, Theo;
Chen, Weisan;
Davis, Ian;
Jackson, Heather;
Dimopoulos, Nektaria;
Barrow, Catherine;
Browning, Judy;
MacGregor, Duncan;
Williams, David;
Hopkins, Wendie;
Maraskovsky, Eugene;
Venhaus, Ralph;
Pan, Linda;
Hoffman, Eric;
Old, Lloyd;
Cebon, Jonathan

Publication type:

Article

Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1635, doi. 10.1007/s00262-009-0672-0

By:

Gedye, Craig;
Quirk, Juliet;
Browning, Judy;
Svobodová, Suzanne;
John, Thomas;
Sluka, Pavel;
Dunbar, P. Rod;
Corbeil, Denis;
Cebon, Jonathan;
Davis, Ian D.

Publication type:

Article

Cancer exploiting complement: a clue or an exception?

Published in:

Nature Immunology, 2008, v. 9, n. 11, p. 1205, doi. 10.1038/ni1108-1205

By:

Loveland, Bruce E;
Cebon, Jonathan

Publication type:

Article

The Ets transcription factor ELF5 functions as a tumor suppressor in the kidney.

Published in:

2011

By:

Lapinskas, Erika J;
Svobodova, Suzanne;
Davis, Ian D;
Cebon, Jonathan;
Hertzog, Paul J;
Pritchard, Melanie A

Publication type:

journal article

The Role of Cancer-Testis Antigens as Predictive and Prognostic Markers in Non-Small Cell Lung Cancer.

Published in:

PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0067876

By:

John, Thomas;
Starmans, Maud H. W.;
Chen, Yao-Tseng;
Russell, Prudence A.;
Barnett, Stephen A.;
White, Shane C.;
Mitchell, Paul L.;
Walkiewicz, Marzena;
Azad, Arun;
Lambin, Philippe;
Tsao, Ming-Sound;
Deb, Siddhartha;
Altorki, Nasser;
Wright, Gavin;
Knight, Simon;
Boutros, Paul C.;
Cebon, Jonathan S.

Publication type:

Article

A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma.

Published in:

PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0048424

By:

Ebert, Lisa M.;
MacRaild, Sarah E.;
Zanker, Damien;
Davis, Ian D.;
Cebon, Jonathan;
Weisan Chen

Publication type:

Article

A Novel HLA-B18 Restricted CD8+ T Cell Epitope Is Efficiently Cross-Presented by Dendritic Cells from Soluble Tumor Antigen.

Published in:

PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0044707

By:

Zhao, Rona Y.;
Mifsud, Nicole A.;
Kun Xiao;
Kok-Fei Chan;
Oveissi, Sara;
Jackson, Heather M.;
Dimopoulos, Nektaria;
Guillaume, Philippe;
Knights, Ashley J.;
Lowen, Tamara;
Robson, Neil C.;
Russell, Sarah E.;
Scotet, Emmanuel;
Davis, Ian D.;
Maraskovsky, Eugene;
Cebon, Jonathan;
Luescher, Immanuel F.;
Weisan Chen;
Le Gall, Sylvie

Publication type:

Article

Frequent MAGE Mutations in Human Melanoma.

Published in:

PLoS ONE, 2010, v. 5, n. 9, p. 1, doi. 10.1371/journal.pone.0012773

By:

Caballero, Otavia L.;
Qi Zhao;
Rimoldi, Donata;
Stevenson, Brian J.;
Suzanne Svobodová;
Devalle, Sylvie;
Röhrig, Ute F.;
Pagotto, Anna;
Michielin, Olivier;
Speiser, Daniel;
Wolchok, Jedd D.;
Liu, Cailian;
Pejovic, Tanja;
Odunsi, Kunle;
Brasseur, Francis;
Van den Eynde, Benoit J.;
Old, Lloyd J.;
Xin Lu;
Cebon, Jonathan;
Strausberg, Robert L.

Publication type:

Article

Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes.

Published in:

1991

By:

Harrison, Leonard C.;
De Aizpurua, Henry;
Loudovaris, Thomas;
Campbell, Iain L.;
Cebon, Jonathan S.;
Tait, Brian D.;
Colman, Peter G.;
Harrison, L C;
De Aizpurua, H;
Loudovaris, T;
Campbell, I L;
Cebon, J S;
Tait, B D;
Colman, P G

Publication type:

journal article

Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report.

Published in:

2020

By:

Hultin, Sebastian;
Nahar, Kazi;
Menzies, Alexander M.;
Long, Georgina V.;
Fernando, Suran L.;
Atkinson, Victoria;
Cebon, Jonathan;
Wong, Muh Geot

Publication type:

journal article

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations.

Published in:

2016

By:

Grasso, Carole;
Anaka, Matthew;
Hofmann, Oliver;
Sompallae, Ramakrishna;
Broadley, Kate;
Hide, Winston;
Berridge, Michael V.;
Cebon, Jonathan;
Behren, Andreas;
McConnell, Melanie J.

Publication type:

journal article

Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells.

Published in:

2016

By:

Jayachandran, Aparna;
Pu-Han Lo;
Chueh, Anderly C.;
Prithviraj, Prashanth;
Molania, Ramyar;
Davalos-Salas, Mercedes;
Anaka, Matthew;
Walkiewicz, Marzena;
Cebon, Jonathan;
Behren, Andreas;
Lo, Pu-Han

Publication type:

journal article

Pharmacokinetic Analysis of Pegylated Megakaryocyte Growth and Development Factor in Humans.

Published in:

Growth Factors, 2000, v. 18, n. 3, p. 215, doi. 10.3109/08977190009003246

By:

De Boer, Richard H.;
Roskos, Lorin K.;
Cheung, Ellen;
Fox, Simon;
Basser, Russell L.;
Marty, Jennifer;
Begley, C. Glenn;
Cebon, Jonathan

Publication type:

Article

A Phase I and Pharmacokinetic Study of Subcutaneously-Administered Recombinant Human Interleukin-4 (rhuIL-4) in Patients with Advanced Cancer.

Published in:

Growth Factors, 2000, v. 17, n. 4, p. 287, doi. 10.3109/08977190009028972

By:

Davis, Ian D.;
Mahera, Darryl W.;
Cebon, Jonathan S.;
Green, Michael D.;
Fox, Richard M.;
McKendrick, Joseph J.;
Rybak, Mary Ellen;
Boyd, Andrew W.

Publication type:

Article

Sphingosine-1-phosphate lyase is expressed by CD68+ cells on the parenchymal side of marginal reticular cells in human lymph nodes.

Published in:

European Journal of Immunology, 2014, v. 44, n. 8, p. 2425, doi. 10.1002/eji.201344158

By:

Park, Saem Mul;
Angel, Catherine E.;
McIntosh, Julie D.;
Brooks, Anna E. S.;
Middleditch, Martin;
Chen, Chun ‐ Jen J.;
Ruggiero, Katya;
Cebon, Jonathan;
Rod Dunbar, P.

Publication type:

Article

Flt3 ligand expands CD4+ Fox P3+ regulatory T cells in human subjects.

Published in:

European Journal of Immunology, 2013, v. 43, n. 2, p. 533, doi. 10.1002/eji.201242603

By:

Klein, Oliver;
Ebert, Lisa M.;
Zanker, Damien;
Woods, Katherine;
Tan, Bee Shin;
Fucikova, Jitka;
Behren, Andreas;
Davis, Ian D.;
Maraskovsky, Eugene;
Chen, Weisan;
Cebon, Jonathan

Publication type:

Article

A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 2, p. 157, doi. 10.1007/s00280-005-0152-y

By:

Gan, Hui K.;
Mitchell, Paul L.;
Galettis, Peter;
Davis, Ian D.;
Cebon, Jonathan;
de Souza, Paul;
Links, Matthew

Publication type:

Article

Capture and On-chip analysis of Melanoma Cells Using Tunable Surface Shear forces.

Published in:

Scientific Reports, 2016, p. 19709, doi. 10.1038/srep19709

By:

Tsao, Simon Chang-Hao;
Vaidyanathan, Ramanathan;
Dey, Shuvashis;
Carrascosa, Laura G.;
Christophi, Christopher;
Cebon, Jonathan;
Shiddiky, Muhammad J. A.;
Behren, Andreas;
Trau, Matt

Publication type:

Article

Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations.

Published in:

Scientific Reports, 2015, p. 11198, doi. 10.1038/srep11198

By:

Chang-Hao Tsao, Simon;
Weiss, Jonathan;
Hudson, Christopher;
Christophi, Christopher;
Cebon, Jonathan;
Behren, Andreas;
Dobrovic, Alexander

Publication type:

Article

NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus.

Published in:

International Journal of Cancer, 2015, v. 136, n. 6, p. E590, doi. 10.1002/ijc.29118

By:

Chen, Ji‐Li;
Dawoodji, Amina;
Tarlton, Andrea;
Gnjatic, Sacha;
Tajar, Abdelouahid;
Karydis, Ioannis;
Browning, Judy;
Pratap, Sarah;
Verfaille, Christian;
Venhaus, Ralph R.;
Pan, Linda;
Altman, Douglas G.;
Cebon, Jonathan S.;
Old, Lloyd L.;
Nathan, Paul;
Ottensmeier, Christian;
Middleton, Mark;
Cerundolo, Vincenzo

Publication type:

Article

Development of a novel, quantitative protein microarray platform for the multiplexed serological analysis of autoantibodies to cancer-testis antigens.

Published in:

International Journal of Cancer, 2014, v. 135, n. 8, p. 1842, doi. 10.1002/ijc.28832

By:

Beeton‐Kempen, Natasha;
Duarte, Jessica;
Shoko, Aubrey;
Serufuri, Jean‐Michel;
John, Thomas;
Cebon, Jonathan;
Blackburn, Jonathan

Publication type:

Article

Characterising the phenotypic evolution of circulating tumour cells during treatment.

Published in:

Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-03725-8

By:

Simon Chang-Hao Tsao;
Jing Wang;
Yuling Wang;
Behren, Andreas;
Cebon, Jonathan;
Trau, Matt

Publication type:

Article

Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide.

Published in:

Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-03321-w

By:

Kok Fei Chan;
Gully, Benjamin S.;
Gras, Stephanie;
Beringer, Dennis X.;
Kjer-Nielsen, Lars;
Cebon, Jonathan;
McCluskey, James;
Weisan Chen;
Rossjohn, Jamie

Publication type:

Article

The dissociation of GM-CSF efficacy from toxicity according to route of administration: a pharmacodynamic study.

Published in:

British Journal of Haematology, 1992, v. 80, n. 2, p. 144, doi. 10.1111/j.1365-2141.1992.tb08891.x

By:

Cebon, Jonathan;
Lieschke, Graham John;
Bury, Ross William;
Morstyn, George

Publication type:

Article

Ropporin-1 and 1B Are Widely Expressed in Human Melanoma and Evoke Strong Humoral Immune Responses.

Published in:

Cancers, 2021, v. 13, n. 8, p. 1805, doi. 10.3390/cancers13081805

By:

Da Gama Duarte, Jessica;
Woods, Katherine;
Quigley, Luke T.;
Deceneux, Cyril;
Tutuka, Candani;
Witkowski, Tom;
Ostrouska, Simone;
Hudson, Chris;
Tsao, Simon Chang-Hao;
Pasam, Anupama;
Dobrovic, Alexander;
Blackburn, Jonathan M.;
Cebon, Jonathan;
Behren, Andreas;
Nagore, Eduardo

Publication type:

Article

Is there a role for combined anti–PD‐1/CTLA‐4 checkpoint blockade in the management of advanced biliary tract cancers?

Published in:

Cancer (0008543X), 2023, v. 129, n. 7, p. 1129, doi. 10.1002/cncr.34660

By:

Klein, Oliver;
Kee, Damien;
Nagrial, Adnan;
Markman, Ben;
Underhill, Craig;
Michael, Michael;
Behren, Andreas;
Palmer, Jodie;
Tebbutt, Niall C.;
Carlino, Matteo S.;
Cebon, Jonathan

Publication type:

Article

A pilot study of intrahepatic yttrium‐90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver‐only metastases.

Published in:

Cancer Reports, 2019, v. 2, n. 4, p. N.PAG, doi. 10.1002/cnr2.1183

By:

Arulananda, Surein;
Parakh, Sagun;
Palmer, Jodie;
Goodwin, Mark;
Andrews, Miles C.;
Cebon, Jonathan

Publication type:

Article

Impact of 2-deoxy-2[F-18]fluoro-D-glucose Positron Emission Tomography on the management of patients with advanced melanoma.

Published in:

2005

By:

Harris, Marion T.;
Berlangieri, Salvatore U.;
Cebon, Jonathan S.;
Davis, Ian D.;
Scott, Andrew M.

Publication type:

journal article

Delayed Autoimmune Toxicity Occurring Several Months After Cessation of Anti‐PD‐1 Therapy.

Published in:

Oncologist, 2018, v. 23, n. 7, p. 849, doi. 10.1634/theoncologist.2017-0531

By:

Parakh, Sagun;
Cebon, Jonathan;
Klein, Oliver

Publication type:

Article

Phase II Study of First-Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma.

Published in:

Oncologist, 2017, v. 22, n. 7, p. 780, doi. 10.1634/theoncologist.2017-0058

By:

Abou‐Alfa, Ghassan K.;
Blanc, Jean‐Frederic;
Miles, Steven;
Ganten, Tom;
Trojan, Jörg;
Cebon, Jonathan;
Liem, Andre K.;
Lipton, Lara;
Gupta, Charu;
Wu, Benjamin;
Bass, Michael;
Hollywood, Ellen;
Ma, Jennifer;
Bradley, Margaret;
Litten, Jason;
Saltz, Leonard B.

Publication type:

Article

Directions in the immune targeting of cancer: Lessons learned from the cancer-testis Ag NY-ESO-1.

Published in:

Immunology & Cell Biology, 2006, v. 84, n. 3, p. 303, doi. 10.1111/j.1440-1711.2006.01446.x

By:

NICHOLAOU, THEO;
EBERT, LISA;
DAVIS, IAN D.;
ROBSON, NEIL;
KLEIN, OLIVER;
MARASKOVSKY, EUGENE;
WEISAN CHEN;
CEBON, JONATHAN

Publication type:

Article

Cytokine production in response to Epstein-Barr virus infection of peripheral blood mononuclear cells in vitro.

Published in:

Immunology & Cell Biology, 1993, v. 71, n. 4, p. 259, doi. 10.1038/icb.1993.30

By:

Whittingham, Senga;
Naselli, Gaetano;
Harrison, Leonard C.;
Boyd, Andrew W.;
Cebon, Jonathan;
Jack, Ian

Publication type:

Article

Immunotherapy of melanoma: Targeting defined antigens.

Published in:

Australasian Journal of Dermatology, 1997, v. 38, p. S66, doi. 10.1111/j.1440-0960.1997.tb01014.x

By:

Cebon, Jonathan;
MacGregor, Duncan;
Scott, Andrew;
DeBoer, Richard

Publication type:

Article

PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma.

Published in:

Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.672521

By:

Parakh, Sagun;
Musafer, Ashan;
Paessler, Sabrina;
Witkowski, Tom;
Suen, Connie S. N. Li Wai;
Tutuka, Candani S. A.;
Carlino, Matteo S.;
Menzies, Alexander M.;
Scolyer, Richard A.;
Cebon, Jonathan;
Dobrovic, Alexander;
Long, Georgina V.;
Klein, Oliver;
Behren, Andreas

Publication type:

Article

Cardiac metastases from malignant melanoma.

Published in:

Cancer (0008543X), 1999, v. 85, n. 1, p. 78, doi. 10.1002/(SICI)1097-0142(19990101)85:1<78::AID-CNCR11>3.0.CO;2-5

By:

Gibbs, Peter;
Cebon, Jonathan S.;
Calafiore, Paul;
Robinson, William A.

Publication type:

Article

Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.

Published in:

Expert Review of Clinical Immunology, 2014, v. 10, n. 8, p. 1107, doi. 10.1586/1744666X.2014.929943

By:

Vella, Laura J;
Andrews, Miles C;
Behren, Andreas;
Cebon, Jonathan;
Woods, Katherine

Publication type:

Article

Perspective: cancer vaccines in the era of immune checkpoint blockade.

Published in:

Mammalian Genome, 2018, v. 29, n. 11/12, p. 703, doi. 10.1007/s00335-018-9786-z

By:

Cebon, Jonathan

Publication type:

Article

Migratory cues controlling B‐lymphocyte trafficking in human lymph nodes.

Published in:

Immunology & Cell Biology, 2021, v. 99, n. 1, p. 49, doi. 10.1111/imcb.12386

By:

Park, Saem Mul;
Brooks, Anna ES;
Chen, Chun‐Jen J;
Sheppard, Hilary M;
Loef, Evert Jan;
McIntosh, Julie D;
Angel, Catherine E;
Mansell, Claudia J;
Bartlett, Adam;
Cebon, Jonathan;
Birch, Nigel P;
Dunbar, P Rod

Publication type:

Article

Phosphoproteomic analysis of cell-based resistance to BRAF inhibitor therapy in melanoma.

Published in:

Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00095

By:

Parker, Robert;
Vella, Laura J.;
Xavier, Dylan;
Amirkhani, Ardeshir;
Parker, Jimmy;
Cebon, Jonathan;
Molloy, Mark P.

Publication type:

Article

Embryonic chicken transplantation is a promising model for studying the invasive behavior of melanoma cells.

Published in:

Frontiers in Oncology, 2015, v. 5, p. 1, doi. 10.3389/fonc.2015.00036

By:

Prithviraj, Prashanth;
Jayachandran, Aparna;
Cebon, Jonathan;
McKeown, Sonja J.;
Woods, Briannyn L.

Publication type:

Article

Effects of epithelial to mesenchymal transition on T cell targeting of melanoma cells.

Published in:

Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00367

By:

Woods, Katherine;
Pasam, Anupama;
Jayachandran, Aparna;
Andrews, Miles C.;
Cebon, Jonathan

Publication type:

Article